How many people have SMA?

It is estimated that one in 40 (forty) people in the United Kingdom is a carrier of genetic mutation that causes SMA. When two carriers have a child, there is 25% risk that the child will have SMA. Considering varying life expectancy among SMA types, it is speculated that between 500 and 2,000 people in the UK live with SMA, including children, teenagers and adults with all SMA types.

In an epidemilogical review of SMA commissioned by SMA Support UK, an attempt was made to calculate the total population living with SMA in England. The results of the study suggested that 85 children were born with SMA in England in 2012.

For more information see SMA Support UK: Population Statistic Breakdown.

Latest Posts

  • Calling on all the community to ACT NOW to avoid losing treatments!

    Calling on all the community to ACT NOW to avoid losing treatments!

    Currently, there are two approved treatments for SMA: risdiplam and nusinersen. These treatments were initially approved temporarily under Managed Access Agreements while the NHS and NICE gathered data to assess their cost-effectiveness. Now, as these agreements come to an end, both treatments face a crucial review.

    Read more

  • NICE’s upcoming Multi Technology Assessment for Spinraza and Risdiplam

    NICE’s upcoming Multi Technology Assessment for Spinraza and Risdiplam

    SMA UK are proud to join together with Treat SMA and MDUK to bring you this webinar about NICE’s upcoming Multi Technology Assessment for Spinraza and Risdiplam. 2024 sees the end of the managed access agreements (MAAs) for the two treatments. An expert committee will gather to assess the new clinical and real-world evidence, along…

    Read more

  • Let the battle begin

    Let the battle begin

    This year the Managed Access Agreement for Spinraza and Risdiplam expires. The MAA was put in place five years ago so the pharmaceutical companies could gather more evidence to resubmit to NICE for approval on the NHS with Biogen extending their MAA by a year.

    Read more